Immune checkpoint inhibitors in advanced cholangiocarcinoma: a systematic review of efficacy, safety, and emerging biomarkers.
- DOI
- 10.1186/s43046-026-00381-8
- Published
- 2026 Jul 6
- Container
- Journal of the Egyptian National Cancer Institute
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s43046-026-00381-8,
title = {Immune checkpoint inhibitors in advanced cholangiocarcinoma: a systematic review of efficacy, safety, and emerging biomarkers.},
author = {Nisa FU and Ali M and Khan T and Lohana M and Asif A and Kumari N and Ali M},
year = {2026},
journal = {Journal of the Egyptian National Cancer Institute},
doi = {10.1186/s43046-026-00381-8},
url = {https://doi.org/10.1186/s43046-026-00381-8}
}RIS
TY - JOUR TI - Immune checkpoint inhibitors in advanced cholangiocarcinoma: a systematic review of efficacy, safety, and emerging biomarkers. AU - Nisa FU AU - Ali M AU - Khan T AU - Lohana M AU - Asif A AU - Kumari N AU - Ali M PY - 2026 JO - Journal of the Egyptian National Cancer Institute DO - 10.1186/s43046-026-00381-8 UR - https://doi.org/10.1186/s43046-026-00381-8 ER -
APA
FU, N., M, A., T, K., M, L., A, A., N, K., & M, A. (2026). Immune checkpoint inhibitors in advanced cholangiocarcinoma: a systematic review of efficacy, safety, and emerging biomarkers.. Journal of the Egyptian National Cancer Institute. https://doi.org/10.1186/s43046-026-00381-8